$1.37
-9.3%BioSig Technologies, Inc. recently rebranded as Streamex Corp., effective September 12, 2025, following its merger with Streamex Exchange Corporation. The company shifted focus from healthcare technology to real-world asset tokenization, especially integrating the gold and commodities market into blockchain technology. Streamex provides institutional-grade infrastructure for tokenizing assets powered by a gold-denominated treasury.
No management information found for stex.
During the last 12 months, insiders have purchased $4.65M and sold $25K worth of STEX shares, resulting in $4.62M of net buying activity.
103.7K
125.15K
23.8K
24.91K
+100K
+$100K
1.3M
3.97M
0
0.00
+4.0M
+$3.97M
7.0K
25.06K
0
0.00
+25K
+$25K
133.2K
523.08K
0
0.00
+523K
+$523K
Giustra Frank
10 Percent Owner
$3.84M
Lekstrom Morgan Lee
Director, Officer: Interim Executive Chairman
$630K
Williams Mitchell Young
Officer: Chief Investment Officer
$156K
Marciano Anthony Mark
Director
$20K
Williams Mitchell Young
Director, Officer: Chief Investment Officer
$25K
Strong bullish signal with $4.62M net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Exceptional buy/sell ratio. Buying dramatically outweighs selling—one of the strongest possible insider signals.
Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.
4 insider buyers vs. 1 sellers. Broad-based buying across management team suggests widespread confidence.
Strong confluence of bullish signals: High buy/sell ratio, multiple insiders participating, and recent buying momentum all point to significant insider confidence. This level of coordinated buying often precedes positive developments.
STEX - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2024 N/A | November 20, 2025 | December 31, 2024 | 2024 | |
DEF 14A DEF 14A 2025 N/A | August 04, 2025 | August 04, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | November 18, 2024 | November 18, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | December 01, 2023 | December 01, 2023 | 2023 | |
DEF 14A DEF 14A 2023 N/A | November 03, 2023 | December 18, 2023 | 2023 | |
DEF 14A DEF 14A 2023 N/A | December 29, 2022 | February 07, 2023 | 2023 | |
DEF 14A DEF 14A 2022 N/A | November 07, 2022 | December 20, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | April 30, 2021 | June 28, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | April 29, 2020 | June 26, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | October 07, 2019 | November 18, 2019 | 2019 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.